FDA NDC Directory · JSON-LD · Markdown

OXCARBAZEPINE

NDC 72888-074 · HUMAN PRESCRIPTION DRUG · SUSPENSION

Labeler / ManufacturerAdvagen Pharma Ltd
Marketing categoryAbbreviated NDA (generic) · App ANDA215726
Dosage form / routeSUSPENSION · ORAL
Active ingredientsOXCARBAZEPINE (300 mg/5mL)
Marketing started20220831
Package count1

External sources

Source: openFDA. Public-domain (CC0).